Literature DB >> 28814426

Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis.

Giacomo Emmi1, Giovanni M Rossi1,2, Maria L Urban2, Elena Silvestri1, Domenico Prisco1, Matteo Goldoni3, Augusto Vaglio2.   

Abstract

Entities:  

Keywords:  ANCA-associated vasculitis; biologicals; eosinophilic granulomatosis with polyangiitis; rituximab

Mesh：

Substances：

Year:  2017        PMID： 28814426     DOI： 10.1136/annrheumdis-2017-211897

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].

Authors:  Bernhard Hellmich; Julia Holle; Frank Moosig
Journal:  Z Rheumatol       Date:  2022-01-24       Impact factor: 1.372

2.  Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.

Authors:  Vítor Teixeira; Aladdin J Mohammad; Rachel B Jones; Rona Smith; David Jayne
Journal:  RMD Open       Date:  2019-06-05

Review 3.  Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology.

Authors:  Filippo Fagni; Federica Bello; Giacomo Emmi
Journal:  Front Med (Lausanne)       Date:  2021-02-24

Review 4.  Eosinophils from Physiology to Disease: A Comprehensive Review.

Authors:  Giuseppe A Ramirez; Mona-Rita Yacoub; Marco Ripa; Daniele Mannina; Adriana Cariddi; Nicoletta Saporiti; Fabio Ciceri; Antonella Castagna; Giselda Colombo; Lorenzo Dagna
Journal:  Biomed Res Int       Date:  2018-01-28       Impact factor: 3.411

5.  Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.

Authors:  Alessandra Bettiol; Maria Letizia Urban; Lorenzo Dagna; Vincent Cottin; Franco Franceschini; Stefano Del Giacco; Franco Schiavon; Thomas Neumann; Giuseppe Lopalco; Pavel Novikov; Chiara Baldini; Carlo Lombardi; Alvise Berti; Federico Alberici; Marco Folci; Simone Negrini; Renato Alberto Sinico; Luca Quartuccio; Claudio Lunardi; Paola Parronchi; Frank Moosig; Georgina Espígol-Frigolé; Jan Schroeder; Anna Luise Kernder; Sara Monti; Ettore Silvagni; Claudia Crimi; Francesco Cinetto; Paolo Fraticelli; Dario Roccatello; Angelo Vacca; Aladdin J Mohammad; Bernhard Hellmich; Maxime Samson; Elena Bargagli; Jan Willem Cohen Tervaert; Camillo Ribi; Davide Fiori; Federica Bello; Filippo Fagni; Luca Moroni; Giuseppe Alvise Ramirez; Mouhamad Nasser; Chiara Marvisi; Paola Toniati; Davide Firinu; Roberto Padoan; Allyson Egan; Benjamin Seeliger; Florenzo Iannone; Carlo Salvarani; David Jayne; Domenico Prisco; Augusto Vaglio; Giacomo Emmi
Journal:  Arthritis Rheumatol       Date:  2021-12-30       Impact factor: 15.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.